What is the recommended management of a vesicovaginal fistula that develops after a total abdominal hysterectomy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Vesicovaginal Fistula After Total Abdominal Hysterectomy

For vesicovaginal fistulas developing after total abdominal hysterectomy, initial management should consist of prolonged bladder catheterization for 3-8 weeks, as this achieves spontaneous closure in early-recognized cases; if conservative management fails or the fistula is diagnosed late, surgical repair via transvaginal approach should be performed after waiting a minimum of 4-6 weeks from fistula onset to allow inflammation to resolve. 1, 2

Initial Conservative Management

Attempt bladder drainage first for all post-hysterectomy vesicovaginal fistulas:

  • Insert a urethral catheter immediately upon diagnosis and maintain continuous drainage for 19-54 days (typically 3-8 weeks), as this alone can achieve spontaneous fistula closure without surgery 1
  • This conservative approach is most successful when the fistula is recognized early (within days to weeks of the hysterectomy) and is small to moderate in size 1
  • Monitor for complete resolution of urinary leakage while the catheter remains in place 1
  • Perform CT cystography (not conventional fluoroscopic cystography) to confirm complete healing before catheter removal, as CT has superior diagnostic accuracy for detecting residual fistulous tracts 3

Critical pitfall: Do not rely on clinical examination alone to confirm healing—imaging is mandatory, as residual tracts may be missed clinically 3

Diagnostic Workup When Conservative Management Fails

If urinary leakage persists after 6-8 weeks of catheter drainage, proceed with definitive imaging:

  • Obtain CT cystography with water-soluble contrast (retrograde bladder filling or delayed imaging after IV contrast) as the preferred imaging modality, with 76.5% sensitivity for fistula detection 3
  • Consider MRI pelvis with IV contrast if CT findings are equivocal or if there is concern for complex anatomy, multiple tracts, or active inflammation, as MRI provides superior soft tissue resolution 3
  • Perform cystoscopy to evaluate fistula location (supratrigonal vs. trigonal), size, and proximity to ureteral orifices 4, 5
  • Rule out malignancy before any repair attempt, as malignant fistulae require oncologic resection, never local repair 6

Timing of Surgical Repair

Wait a minimum of 4-6 weeks from fistula onset before attempting surgical repair:

  • This waiting period allows resolution of inflammation, tissue edema, and infection, which dramatically improves surgical success rates 2
  • Repairs performed at 3-8 months post-hysterectomy have been successful in multiple series 5, 7
  • Earlier repair (before 4 weeks) is associated with higher failure rates due to persistent inflammation and poor tissue quality 2

Exception: If the fistula is recognized intraoperatively during the hysterectomy itself, immediate repair can be attempted with multilayer closure and prolonged catheter drainage 4

Surgical Approach Selection

Transvaginal repair should be the preferred approach for most post-hysterectomy vesicovaginal fistulas:

  • Transvaginal repairs achieve 91% success rates (comparable to the 97% success rate of abdominal approaches) while minimizing operative complications, blood loss, hospital stay, and postoperative pain 2
  • The Latzko partial colpocleisis technique or layered closure with or without Martius flap are the most commonly used transvaginal methods 2
  • Transvaginal approach is appropriate even for supratrigonal fistulas, which constitute the majority of post-hysterectomy cases 5

Transabdominal approach (open or laparoscopic) is indicated when:

  • The fistula is large (>2-3 cm), complex, or involves the trigone with proximity to ureteral orifices 4, 2
  • Previous transvaginal repair has failed 2, 7
  • There is inadequate vaginal access or capacity 2
  • The patient has had prior pelvic radiation (though success rates drop to 40-100% in radiated tissue) 8, 2

Laparoscopic transperitoneal repair technique (when abdominal approach is chosen):

  • Use a five-port transperitoneal approach with the patient in deflected supine position 5
  • Bivalve the bladder to expose the fistula from within 5
  • Excise the fistulous tract completely 5
  • Close the vaginal defect and bladder defect in separate, non-overlapping layers 4, 5
  • Interpose an omental flap or peritoneal flap between the bladder and vaginal suture lines to prevent recurrence 4, 5, 7
  • This approach achieved 100% success in primary repairs in one series 7

Surgical Principles for All Approaches

Adhere to these fundamental principles regardless of approach:

  • Completely separate and mobilize the bladder wall from the vaginal wall 4
  • Sharply excise all fibrotic fistulous tract tissue to healthy, well-vascularized edges 4, 7
  • Close defects in multiple layers with non-overlapping suture lines 4
  • Interpose vascularized tissue (omental flap, peritoneal flap, or Martius labial fat pad graft) between the bladder and vaginal closures 4, 2, 7
  • Ensure tension-free closure 2
  • Maintain prolonged bladder drainage (10-14 days postoperatively) with urethral catheter 5

Postoperative Management

  • Perform retrograde cystography on postoperative day 10 to confirm no contrast leakage before catheter removal 5
  • If cystography shows persistent leakage, continue catheter drainage for an additional 1-2 weeks and repeat imaging 1
  • Hospital discharge typically occurs 4-9 days postoperatively for laparoscopic repairs 5

Management of Failed Primary Repair

If the first repair fails (occurs in 9-25% of cases):

  • It is acceptable to repeat the repair through a transvaginal approach even after a first transvaginal failure 2
  • Secondary transvaginal repair achieves 50% success, while secondary transvesical repair achieves only 33% success 7
  • If the second repair fails, strongly consider transabdominal approach with omental flap interposition, which achieved 100% success in tertiary and quaternary repairs in one series 7
  • Cumulative success rates after multiple attempts reach 83-96% 7

Critical pitfall: Do not perform fistulotomy or simple fulguration for vesicovaginal fistulae, as these techniques are contraindicated and will fail 8, 6

Special Consideration: Radiation-Associated Fistulae

For fistulae developing after pelvic radiation therapy (not applicable to simple post-hysterectomy cases but important to recognize):

  • Success rates drop to 40-100% due to poor tissue vascularity and healing 2
  • These require more individualized and complex surgical procedures, often with tissue flaps 2
  • Many institutions prefer urinary diversion for radiation-associated fistulae due to high failure rates of local repair 2
  • Ureteral dose >23.1 Gy EQD2 is associated with 10% risk of grade 3+ urinary toxicity including fistula formation 8

References

Research

Guidelines of how to manage vesicovaginal fistula.

Critical reviews in oncology/hematology, 2003

Guideline

Imaging Guidelines for Vesicovaginal Fistula Repair

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Rectovaginal and Vesicovaginal Fistulae

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Treatment of vesicovaginal fistulas: an experience of 30 cases.

Medical archives (Sarajevo, Bosnia and Herzegovina), 2013

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.